BUSINESS● LOW3h ago · Oct 19, 2026, 3:58 PM
Regeneron-backed Parabilis rises ahead of trial data for lead asset
Seeking Alpha Tech · global
Parabilis, a company backed by Regeneron, has seen its stock rise in anticipation of trial data for its primary asset. This indicates market reaction to expected corporate news.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowCritical minerals: why development banks are making a comeback in the sectorJeune AfriqueBUSINESS34m agoOccidental Petroleum raised to Buy at Roth as one of better ways to play oil upsideSeeking Alpha Tech